MicroRNA Dysregulation in B-Cell Non-Hodgkin Lymphoma

Blood and Lymphatic Cancer: Targets and Therapy
doi 10.2147/blctt.s44343
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Expression of PAX-5 in B Cell Hodgkin and Non Hodgkin Lymphoma

Asian Pacific Journal of Cancer Prevention
2018English

Subcutaneous Rituximab in B-Cell Non-Hodgkin Lymphoma: A Single-Center Experience

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Choosing the Appropriate Salvage Therapy for B-Cell Non-Hodgkin Lymphoma

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2018English

Regulation of CD20 in Rituximab-Resistant Cell Lines and B-Cell Non-Hodgkin Lymphoma

Clinical Cancer Research
Cancer ResearchOncology
2012English

Autologous Stem Cell Transplantation Outcomes in Elderly Patients With B Cell Non-Hodgkin Lymphoma

British Journal of Haematology
Hematology
2015English

Emerging Role of Podocalyxin in the Progression of Mature B-Cell Non-Hodgkin Lymphoma

Cancers
Cancer ResearchOncology
2020English

Non-Hodgkin Lymphoma

2020English

Synchronous Occurrence of B-Cell Non Hodgkin Lymphoma and Metastatic Small Cell Carcinoma of Lung

National Journal of Health Sciences
2017English

Dynamic Analysis of Human Natural Killer Cell Response at Single-Cell Resolution in B-Cell Non-Hodgkin Lymphoma

Frontiers in Immunology
AllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy